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Abstract
Background: Steroid-based intensive medical therapy for severe ulcerative colitis is successful in 60–70% of such patients.
Patients with complications or those refractory to medical therapy require emergency colectomy for salvage. Little is known
about the impact of timing of surgical intervention and surgical outcomes of such patients undergoing emergency surgery in India
where the diagnosis is often delayed or missed in patients who are poor, malnourished and non-compliant to medical treatment.
Methods: The clinical records of all patients undergoing emergency surgery for severe ulcerative colitis or its complication in
the Department of GI surgery AIIMS, New Delhi, India, between January 1985 and December 2003 were retrieved and data
pertaining to demographic features, duration of intensive medical therapy, presence of complications, time from admission to
emergency surgery, surgical procedure, in-hospital morbidity and mortality and follow up status extracted.
Results: A total of 72 patients underwent emergency surgery (Subtotal colectomy: 60; ileostomy alone under local anaesthesia:
12). Poor nutritional status was seen in 61% of the patients.
Twenty-one patients (29%) underwent emergency surgery for complications of severe ulcerative colitis such as colonic
perforation (spontaneous 6, iatrogenic 4), massive lower gastrointestinal haemorrhage (5), toxic megacolon (4) and large bowel
obstruction (2). The remaining patients (n = 51) underwent emergency surgery following failed intensive therapy; 17 underwent
surgery ≤5 days (Group I) and 34 were operated >5 days (Group II) after initiation of intensive therapy. In this group all the
post-operative deaths (n = 8) occurred in those who were operated after 5 days. The difference in mortality in these two groups
(i.e. surgical intervention ≤ or >5 days) was statistically significant {0/17 (Group I) vs 8/34 (Group II); p = 0.03}.
Overall, 12 patients died (in-hospital mortality: 16.7%). The mortality was higher (10/43; 23.3%) in our early experience (i.e.
1985–1995) when compared to our subsequent experience (2/29; 6.9%) (1996–2003).
A total of 48 patients (including 3 awaiting a restorative procedure) are alive on follow up (66.7%; 3 patients lost to follow up).
A restorative procedure could be successfully completed in 81% of the survivors of the emergency procedure.
Conclusion: To optimize the outcome, a combined team of physicians and surgeons should be involved in the management of
patients with severe ulcerative colitis with focus on nutritional support, correction of metabolic derangements, close clinical
monitoring and timely assessment for the need for emergency surgery. This retrospective analysis shows that improved results
can be achieved with experience and by following a policy of early surgical intervention within 5 days, especially in patients who
have failed intensive medical therapy.
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Background
It is known that about 20% of patients with ulcerative col-
itis, suffer from severe acute relapse and its associated
complications at some point in the course of their illness
[1,2]. Overall, 5–10% of patients with ulcerative colitis
present with a severe first attack. The relapse-free interval
in a given patient remains unpredictable. However, long-
term prospective cohort studies have shown that virtually
all patients will relapse and develop acute exacerbation at
some point in the course of their illness [1,2]. Intensive
medical treatment (Oxford regimen) is successful in
60%–70% of patients suffering from severe ulcerative col-
itis, but the rest require emergency surgery either for a
complication or because they fail to respond to medical
therapy [3-6]. Among those who respond to intensive
medical therapy, a colectomy will be required in up to
50% within a year and in at least 75% at around 5 years of
follow up [6,7]. Emergency surgery in anaemic, nutrition-
ally depleted, immunosuppressed and toxic patients has a
high morbidity and mortality [8,9]. Little is known about
the outcome of patients with acute severe ulcerative colitis
undergoing emergency surgery in India. We hypothesized
that Indian patients with ulcerative colitis may behave dif-
ferently because they are poor (have difficulty in purchas-
ing drugs) and often illiterate (do not understand the
importance of continuing medication and follow up) and
the diagnosis is often delayed because of the high inci-
dence of infective diarrhoea and dysentery. We therefore
analyzed our experience of emergency surgery in patients
with ulcerative colitis focusing on two main issues, i.e. the
timing of surgery and the immediate as well as long term
outcome following emergency surgery.
Methods
All patients undergoing emergency surgery for severe
ulcerative colitis or its complication in the Department of
GI Surgery, All India Institute of Medical Sciences, New
Delhi, between January 1985 and December 2003 had a
pre-designed proforma filled. The details recorded
included demographic features of the patients, duration
of intensive medical therapy during the index admission,
presence of complications (toxic megacolon, perforation,
lower gastrointestinal haemorrhage, intestinal obstruc-
tion and colorectal cancer), time from initiation of inten-
sive therapy to emergency operation, indication for
emergency surgery, type of surgical procedure, postopera-
tive complications, in-hospital mortality, delayed deaths
during follow up, outcome of any further operative proce-
dures and current status. The collected data was retrospec-
tively analyzed.
A severe episode of ulcerative colitis was defined accord-
ing to Truelove and Witt's criteria [3] as: >6 bloody stools/
day, fever ≥ 38°C, tachycardia > 100/min, anemia and/or
an erythrocyte sedimentation rate > 30 mm in 1st hour.[3]
All patients diagnosed to have severe ulcerative colitis
were admitted in the Gastroenterology department of our
institution and were managed jointly, from the time of the
admission, by a team comprising of physicians and sur-
geons. Nutritional status at admission was judged by a
combination of subjective clinical assessment, body
weight record (labeled underweight when <10th percentile
of their expected weight as per sex and height) and serum
albumin levels <3.0 g/dl was considered low. Intensive
medical therapy included parenteral steroids (100 mg
hydrocortisone intravenously 6 hourly), nil by mouth,
nasogastric aspiration, intravenous crystalloids and elec-
trolytes, parenteral nutritional support, blood transfu-
sions and broad spectrum parenteral antibiotics (third-
generation cephalosporins, aminoglycosides and metron-
idazole). The indications for emergency surgery included
lack of response to or deterioration while on intensive
medical therapy and presence of complications at admis-
sion. Patients who continued to have high stool frequency
(>6 motions/day), persistent hematochezia, deteriorated
clinically, developed steroid toxicity and/or complica-
tions and/or remained intolerant to oral feeding were
judged to have failed to respond to intensive medical ther-
apy. In our practice (before this study), duration of inten-
sive therapy did not exclusively influence the decision to
operate or label a patient refractory to intensive therapy.
Operative procedures
A subtotal colectomy with Hartmann's pouch (STC) was
done in most patients. This included removal of the dis-
eased ascending, transverse, descending and the sigmoid
colon with closure of the sigmiodorectal stump at or
above the level of sacral promontory without any pelvic
mobilization of the rectum. When the rectal stump was
unhealthy because of severe rectal disease or when there
was ongoing rectal bleeding the open end was brought
out as a mucus fistula through the anterior abdominal
wall. Some patients underwent an initial loop ileostomy
under local anaesthesia, as they were considered too ill to
withstand a colectomy under general anaesthesia. Subse-
quently, in the same hospital admission or at an early
readmission these patients underwent a subtotal colec-
tomy.
All patients were counseled regarding the long-term bene-
fits/disadvantages of a restorative proctectomy with an
ileal pouch (J reservoir) anal anastomosis (IPAA) [10,11].
Depending on their motivation and acceptance a restora-
tive procedure with a diverting loop ileostomy was then
done 3–6 months after the emergency colectomy. Finally,
6 weeks later, the ileostomy was closed after obtaining a
pouchogram.BMC Gastroenterology 2005, 5:39 http://www.biomedcentral.com/1471-230X/5/39
Page 3 of 8
(page number not for citation purposes)
Follow up protocol
Patients were followed up at 3-monthly intervals in the
first year, 6-monthly intervals in the second year and at
yearly intervals thereafter. Patients who defaulted were
sent postal reminders and questionnaires to ascertain
their current status. At each visit the patients underwent a
general physical examination, their weight was noted,
laparotomy wound and ileostomy site were inspected and
patients who had had the ileostomy closed were inter-
viewed regarding their bowel frequency and continence.
Periodic complete blood counts and liver function tests
were also done.
The primary outcome measure was operative mortality.
The factors which could have influenced the patient out-
come such as duration of disease, long term use of steroids
or azathioprine, presence of fever, co morbid illnesses,
preoperative hemoglobin, total leucocyte count and
serum albumin levels were also recorded. We also ana-
lyzed the surgical outcome in relation to duration of
intensive medical management in the index admission.
For this purpose we divided the patients who were consid-
ered failures of intensive medical therapy into 2 groups:
those who underwent surgery ≤ and >5 days after the ini-
tiation of intensive medical therapy.
Statistical methods
The information was entered in a MS Access format and
analyzed using the SPSS version 11.5 software. For com-
parison, non-parametric tests such as Pearson's chi square
test and for continuous variables student's t test were used.
A p value less than 0.05 was considered significant. A uni-
variate analysis was done to determine any association of
operative mortality with duration of intensive medical
therapy, age, preoperative nutritional status duration of
disease, long term use of steroids, presence of fever, co
morbid illnesses, preoperative hemoglobin, total leuco-
cyte count and serum albumin levels. To identify a cut-off
point with regard to duration of intensive medical therapy
a receiver-operator characteristic (ROC) curve was plotted
and the point on the curve giving the highest sensitivity
for the primary outcome measure(postoperative death)
was used for the subsequent analysis.
Results
Between 1985–2003, 154 (88 males) patients underwent
operations for ulcerative colitis out of whom 72 (46.5%)
underwent emergency surgery. The mean age was 34.8 ±
12.8 years (range: 14–72 years; median: 32 years). The
nutritional status of 61% of these patients was poor and
the mean serum albumin level was 2.6 g/dl (range: 1.3–
4.8 g/dl). Failure of intensive medical therapy was the
most common indication for emergency surgery (n = 51;
71%) patients. In these patients the interval between ini-
tiation of intensive medical therapy at our hospital and
emergency surgery varied between 3–35 days with a mean
of 9 days (median: 6 days). The remaining 21 (29%)
patients had presented with complications such as colonic
perforation (spontaneous 6, iatrogenic 4), massive lower
gastrointestinal haemorrhage (5), toxic megacolon (4)
and large bowel obstruction (2). A majority of these
patients underwent urgent/emergent surgery even before a
trial of intensive drug therapy could be initiated.
Surgery
The most common emergency surgical procedure was a
sub total colectomy with a Hartmann's pouch or mucus
fistula (n = 60; 83.3%). A diverting loop/divided ileos-
tomy alone (under local anaesthesia) was the initial pro-
cedure in 12 patients. Ileostomy was more frequently used
as the initial procedure in the later period of our experi-
ence (i.e., 1996–2003; 10/29 patients vs. 2/43; p = 0.003).
Postoperative morbidity
The overall morbidity included major wound sepsis with
or without wound dehiscence (27; 37.5%), fever (20;
27.8%), adhesive intestinal obstruction (8.3%), pelvic
sepsis (6.6%), ileostomy-related complications (6.6%),
blow out of Hartmann's pouch (6.6%) and continued rec-
tal bleeding (3.3%). The median duration of postopera-
tive hospital stay was 10 days.
Postoperative mortality
Overall, 12 (STC: 10/60; Ileostomy: 2/12) patients died
postoperatively in the same admission giving an in-hospi-
tal mortality of 16.7%. Eight patients died in the sub
group operated following failure of intensive medical
therapy (8/51; 15.7%) whereas 4 died following surgery
for complications (4/21; 19%). Notably, all patients with
perforations alone (n = 10) survived the emergency sur-
gery.
The causes of death included septicaemia in 6, severe chest
infection with respiratory failure in 2, disseminated intra-
vascular coagulation in 1, diabetic ketoacidosis in 1, met-
abolic encephalopathy in 1 and upper gastrointestinal
bleeding (stress bleeding) in 1. By using chi square tests it
was found that the risk of death increased in those
patients who had postoperative fever (p = 0.01), ileos-
tomy-related complications (p = 0.02) or evidence of peri-
Table 1: Operative mortality with regard to indication and 
timing*
Indication n Died Mortality (%) >5 d
Refractory severe UC 51 8 15 8
Severe LGIH 5 2 40 0
Toxic megacolon 4 2 50 1
* No mortality in perforation and obstruction group
UC: ulcerative colitis; LGIH: Lower gastrointestinal haemorrhageBMC Gastroenterology 2005, 5:39 http://www.biomedcentral.com/1471-230X/5/39
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tonitis at surgery (p = 0.018). Also, the patients who died
had lower preoperative albumin levels (mean albumin:
2.25 ± 0.5 g/dl vs 2.73 ± 0.8 g/dl; p = 0.08).
We also found that the mortality was higher (10/43;
23.3%) in our early experience (i.e. 1985–1995) when
compared to our subsequent experience (2/29; 6.9%)
(1996–2003).
Timing of surgery
Twenty-one patients had emergency surgery for complica-
tions and in 51 patients the indication was failure of
intensive medical therapy. In the 21 patients undergoing
surgery for complications the occurrence of the complica-
tion determined the timing of the surgery. In this group,
often surgery was done shortly after admission (i.e. in
patients with perforation, severe bleeding or obstruction).
On analyzing the data of the patients who underwent
emergency surgery for failed intensive therapy (n = 51),
statistical analysis with regard to mortality as the primary
outcome measure showed that the only variable that
influenced the outcome significantly was the timing of
surgery from the initiation of intensive medical therapy. A
cut-off time period of 5 days was obtained after plotting a
ROC curve with death as the primary outcome measure.
In this group 17 patients underwent surgery ≤ 5 days and
the rest (n = 34) were operated >5 days after initiation of
intensive therapy. The operative outcome of each group
was further analyzed. All the post-operative deaths (n = 8)
occurred in those who were operated after 5 days (Table
1). The difference in mortality in the two groups based on
the timing of surgery (i.e. ≤ or >5 days) was statistically
significant {0/17 (Group I) vs 8/34 (Group II); p = 0.03}.
These two groups were otherwise comparable in terms of
the nutritional status, age, sex, and associated co-morbid-
ities. Table 2 summarizes the salient clinical, demographic
and laboratory data pertaining to these two groups of
patients who failed intensive medical therapy. The groups
did not show any significant difference in any of the vari-
ables compared.
Long term outcome
Two patients died at home (6 weeks; 8 weeks) after being
discharged alive from hospital of which one patient who
had severe associated comorbidity in the form of valvular
heart disease with infective endocarditis, died of a sus-
pected cerebral thromboembolic phenomenon and
another patient died of disseminated colorectal cancer.
The ultimate outcome of each patient presenting to us for
emergency surgery is summarized in Figure 1 and Table 3.
All surviving patients have been followed up for a mean
period of 39 months (range: 3–216 months). Of the 58
(12 postoperative and 2 late deaths) patients who sur-
vived the emergency procedure, 3 patients were lost to fol-
low up, 2 refused a second stage IPAA and 2 were not
offered because of extensive small bowel tuberculosis in
one and low rectal cancer in another. Hence, 51 patients
were available for a 2nd stage restorative proctectomy. In
these, IPAA was done in 46 patients, one patient is alive
and well following an ileorectal anastomosis (IRA), one
other patient is alive and well following a total procto-
colectomy (TPC) with Brooke's ileostomy (a 65 year old
patient who had poor anal sphincter tone opted for a
TPC) and 3 are awaiting a restorative surgery. One patient
died following the pouch procedure and there were 2 late
deaths on long term follow up.
A total of 48 patients (including 3 awaiting a restorative
procedure) are alive on follow up, from the initial cohort
of 72 patients (66.7%; status of 3 patients lost to follow
Table 2: Clinical, biochemical and demographic data of the patients who failed intensive medical therapy (n = 51) according to the 2 
subgroups (Group I: those operated ≤5 days and Group II >5 days after initiation of intensive steroid therapy).
Variable Group I* (n = 17) 
Mean (± SEM)
Group II* (n = 34) 
Mean (± SEM)
Age (years) 33 (3.8) 35 (2)
Disease duration (months) 48 (15.2) 32 (6.7)
Stool frequency/day 10.2 (0.9) 11.9 (0.9)
Pulse rate (/minute) 92 (5.3) 98 (2.5)
Poor nutritional status# 9 (56%) 22 (64%)
Hemoglobin (g/dl) 9.9 (0.6) 9.4 (0.4)
ESR (mm) 41 (7.1) 44.8 (4.3)
Urea (mg/dl) 22.2 (1.9) 26.3 (4.8)
Serum albumin (g/dl) 2.8 (0.14) 2.5 (0.13)
* On statistical comparison none of these variables were found to be significantly different
# Number of patients classified as having poor nutritional status
SEM - Standard error of meansBMC Gastroenterology 2005, 5:39 http://www.biomedcentral.com/1471-230X/5/39
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up not known). The restorative procedure (IPAA, IRA,
TPC) could be successfully completed in 81% of the sur-
vivors of the emergency procedure (47/58 with 1 postop-
erative death). Of these 45 patients are alive and doing
well.
Discussion
Before 1950, the expected mortality of a patient with acute
severe ulcerative colitis was as high as 40–50% [1-3]. Such
a patient was a physician's nightmare, as the surgeons
never came in the picture. Truelove and Witts introduced
steroid therapy in the 1950s [3,4]. With this, the mortality
decreased to 8–10%, but rates as high as 18% have been
reported [4-6]. The last milestone in therapy came in the
1960's after Brooke and Sampson proposed emergency
total colectomy for salvage of patients following failure of
medical therapy [12].
Flow chart showing the procedures done and outcome (short and long term) Figure 1
Flow chart showing the procedures done and outcome (short and long term). IPAA: ileal J Pouch anal anastomosis; 
IRA: ileorectal anastomosis; TPC: total proctocolectomy with permanent Brooke's ileostomy; FU: follow up; LFU: lost to fol-
low up. * One patient had rectal cancer receiving adjuvant therapy and IPAA was not contemplated; the other patient devel-
oped intestinal tuberculosis and recurrent small bowel obstruction with multiple reoperations, hence pouch was not 
advocated. # One patient died of massive cerebral thromboembolism secondary to valvular heart disease with infective endo-
carditis; one additional patient died of disseminated colorectal cancer.BMC Gastroenterology 2005, 5:39 http://www.biomedcentral.com/1471-230X/5/39
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The timing of the emergency surgery is of crucial impor-
tance for these patients, as procrastination leads to wors-
ening of the patient's general condition and nutritional
status. To begin with, nearly two-thirds of the patients in
this series were poorly nourished and hypoalbuminemic
before surgery. It has been shown previously that the sur-
gical outcome worsens with delay beyond 5–7 days of
intensive medical therapy [8,13]. Our data supports this
view, as the operative mortality in the group of patients
who failed intensive medical therapy and were operated
late (i.e., beyond 5 days) was high when compared to the
group operated within 5 days (8/34 vs. 0/17; p = 0.03). In
fact, all the post-operative deaths (n = 8) occurred in
patients who were operated on after 5 days. This differ-
ence in mortality in the two groups based on timing of
surgery is statistically significant. A univariate analysis of
this group could not identify any other significant risk fac-
tor for mortality (Table 2). In 46 patients (i.e., 64% of the
total patient population n = 72), multiple factors were
responsible for a delay >5 days in surgical intervention.
Some patients had shown an initial response to intensive
medical therapy but had a relapse or developed a compli-
cation in the same hospitalization; some had associated
comorbid conditions in the form of heart disease, uncon-
trolled diabetes or tuberculosis while some were referred
late from other hospitals.
In patients who present with complications such as perfo-
ration or massive colonic bleeding, emergency surgery
should be performed as soon as possible. In patients with
toxic megacolon a short period of conservative manage-
ment (24–48 hours) may be beneficial [2,14]. In patients
with large bowel obstruction usually 48–72 hours of pre-
operative preparation is necessary to optimize the surgical
outcome. Similar to other reports in the literature,
patients with a combination of toxic megacolon, perfora-
tion and fecal peritonitis had the poorest outcomes
[2,8,14].
On analyzing the cause of death (pertaining to the entire
study group) we found that 8 patients died of septicaemia,
the remaining 4 had severe metabolic disturbances with
encephalopathy, coagulopathy and respiratory failure
from which they could not be salvaged. A combination of
severe metabolic derangement along with pre existing sep-
sis (fecal peritonitis) or coagulopathy was lethal. In only
one of the patients who died due to the metabolic seque-
lae (diabetic ketoacidosis) of pre-existing insulin-depend-
ent diabetes mellitus, death could be attributed to
comorbidity. As mentioned earlier, the overall postopera-
tive mortality was higher (10/43; 23.3%) in our early
experience (i.e. 1985–1995) when compared to our sub-
sequent experience (2/29; 6.9%). We can only hypothe-
size that this improvement in operative outcome was in
part due to the institution of an aggressive medical man-
agement protocol (following 1996) with early parenteral
nutrition and emphasis on correction of metabolic
derangements preoperatively. Another factor that could
have improved the results was the conscious decision to
use a decompressing ileostomy alone, as the first stage
procedure, in very sick and moribund patients (Post-
1996:10/29; 34.5% vs Pre-1996: 2/43; 4.7%; p = 0.003).
Although the data is limited, we believe that this approach
allows us to buy time and improve the patients overall
condition so that the patient is able to withstand colec-
tomy at a later date. Our current mortality figures are com-
parable to most other western series [8,9,15].
Following sub total colectomy (STC), the commonest
morbidity was related to wound sepsis and postoperative
fever. Patients with peritonitis at operation, those who
developed postoperative fever or had ileostomy related
complications were more likely to die postoperatively. In
our experience there were 4 (6.6%) instances with stump
'blow outs' which caused pelvic sepsis and abdominal
wound dehiscence and led to a prolonged hospital stay.
Bleeding from the Hartmann's pouch did occur in a few
patients (3.3%), but was managed with a combination of
mesalamine and steroid enemas, local adrenaline saline
lavages or by tapering the steroids slowly. A Hartmann's
procedure or a mucus fistula of the rectal stump has been
recommended by other workers also [16].
In the emergency setting, it is believed that a subtotal
colectomy is the best option as it is technically simple,
avoids dissection in the pelvis, minimizes blood loss and
allows a subsequent restorative pouch procedure
[8,9,15,17]. It also allows a definitive histological diagno-
sis to be obtained. In our study, all patients who had STC
and survived (n = 60), were weaned off steroids after a
month. Fifty-eight patients (2 late deaths) recovered fully
and gained weight. Out of the 56 patients finally consid-
ered eligible for a second stage IPAA procedure, 47 under-
went a second stage procedure (IPAA: 46; IRA: 1) with 1
postoperative death following an IPAA (Figure 1 and
Table 3). The details of the patients' management have
been listed in the flow chart (Figure 1). The second stage
Table 3: The ultimate fate of each patient undergoing 
emergency sub total colectomy (STC)
Total patients surviving STC 58
Lost to follow up 3
Refused pouch 2
Pouch not offered 2
Patients eligible for 2nd stage 51
Total IPAA done 46
IRA done 1
TPC 1
Awaiting 3BMC Gastroenterology 2005, 5:39 http://www.biomedcentral.com/1471-230X/5/39
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could be successfully performed in 81% (47/58) of the
cases who survived the first procedure. Notably, by the
time the patients undergo the 2nd stage procedure, the
postoperative results obtained are similar to what can be
achieved by an elective restorative proctocolectomy done
in a patient with long-standing disease. Our second stage
operative mortality was low at 2.1% (1/47) and compara-
ble to the mortality rate in the elective setting (1/69; 1.5%;
unpublished data). From the initial cohort of 72 patients,
48 patients are alive on follow up. Hence, two-third of the
patients have been successfully salvaged and rehabilitated
by staged surgery for severe ulcerative colitis. It is worth
emphasizing here that the long term results of salvage and
rehabilitation reflect the survival rate following the initial
emergency surgery, as is apparent from our experience.
This attrition following the first stage surgery is often una-
voidable in 10–15% of cases because of late deaths, inci-
dental detection of malignancy/Crohn's or indeterminate
colitis [17], refusal for further surgery, associated intesti-
nal/miliary tuberculosis and other co-morbid illnesses.
Based on this experience we feel that in order to achieve a
good postoperative outcome a combined team of physi-
cians and surgeons should be involved in the manage-
ment of patients with severe ulcerative colitis right from
the day of admission. Aggressive nutritional therapy and
correction of metabolic derangements combined with
close clinical monitoring should be instituted along with
the intensive steroid regimen [18-20]. Need for surgery
should be assessed in advance [7,21] and early surgery is
recommended in the event of failed medical treatment. In
a majority of such cases a sub total colectomy is the pro-
cedure of choice and gives the best results. A loop ileos-
tomy alone can be used in severely ill and moribund
patients to buy time for a subsequent colectomy. These
measures, when strictly implemented, would help to
achieve a low and acceptable mortality rate.
In India, emergency surgery for salvaging ulcerative colitis
will continue to play an important role as few medical
centers have the experience and resources to treat such
patients with optimal skill and judgment, and nearly a
third of the patients are refractory to intensive medical
therapy. In consonance with the experience of other west-
ern centers [8,9,13], our retrospective analysis has rein-
forced that improved results can be achieved with
experience and by following a policy of early surgical
intervention within 5 days, especially in patients who
have failed intensive medical therapy. Since immediate
operative outcome is linked to the timing of the surgery,
emphasis on anticipating failures of intensive medical
therapy early is crucial for optimal decision-making and
successful rehabilitation of these patients.
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